Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains

Brigitte Eisensamer, Manfred Uhr, Sabrina Meyr, Gerald Gimpl, Tobias Deiml, Gerhard Rammes, Jeremy J. Lambert, Walter Zieglgänsberger, Florian Holsboer, Rainer Rupprecht

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Despite different chemical structure and pharmacodynamic signaling pathways, a variety of antidepressants and antipsychotics inhibit ion fluxes through 5-HT3 receptors in a noncompetitive manner with the exception of the known competitive antagonists mirtazapine and clozapine. To further investigate the mechanisms underlying the noncompetitive inhibition of the serotonin-evoked cation current, we quantified the concentrations of different types of antidepressants and antipsychotics in fractions of sucrose flotation gradients isolated from HEK293 (human embryonic kidney 293) cells stably transfected with the 5-HT3A receptor and of N1E-115 neuroblastoma cells in relation to the localization of the 5-HT3 receptor protein within the cell membrane. Western blots revealed a localization of the 5-HT 3 receptor protein exclusively in the low buoyant density (LBD) fractions compatible with a localization within raft-like domains. Also, the antidepressants desipramine, fluoxetine, and reboxetine and the antipsychotics fluphenazine, haloperidol, and clozapine were markedly enriched in LBD fractions, whereas no accumulation occurs for mirtazapine, carbamazepine, moclobemide, and risperidone. The concentrations of psychopharmacological drugs within LBD fractions was strongly associated with their inhibitory potency against serotonin-induced cation currents. The noncompetitive antagonism of antidepressants at the 5-HT3 receptor was not conferred by an enhancement of receptor internalization as shown by immunofluorescence studies, assessment of receptor density in clathrin-coated vesicles, and electrophysiological recordings after coexpression of a dominant-negative mutant of dynamin I, which inhibits receptor internalization. In conclusion, enrichment of antidepressants and antipsychotics in raft-like domains within the cell membrane appears to be crucial for their antagonistic effects at ligand-gated ion channels such as 5-HT3 receptors.

Original languageEnglish
Pages (from-to)10198-10206
Number of pages9
JournalJournal of Neuroscience
Volume25
Issue number44
DOIs
Publication statusPublished - 2 Nov 2005

Keywords

  • 5-HT receptor
  • Antidepressants
  • Antipsychotics
  • Ligand-gated ion channel
  • Lipid rafts
  • Receptor internalization

Fingerprint Dive into the research topics of 'Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains'. Together they form a unique fingerprint.

  • Cite this

    Eisensamer, B., Uhr, M., Meyr, S., Gimpl, G., Deiml, T., Rammes, G., Lambert, J. J., Zieglgänsberger, W., Holsboer, F., & Rupprecht, R. (2005). Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. Journal of Neuroscience, 25(44), 10198-10206. https://doi.org/10.1523/JNEUROSCI.2460-05.2005